Texas A&M researchers develop nanoclay bioinks for controlled therapeutics

A researcher from Texas A&M University has come up with a novel bioprinting technique that overcomes a number of existing challenges in printing 3D therapeutics for regenerative medicine. At the crux of the breakthrough is a new nanoclay platform, which makes bioprinting growth factors more feasible.

One of the hurdles facing bioprinting researchers today is the ability to properly control cellular functions. Incorporating growth factors, which are a special class of protein, into bioprinting materials can help to control and direct cellular functions, though up until now they have been challenging to integrate into a printed structure.

Read full article

More News